Methylation and prognosis: Of molecular clocks and hypermethylator phenotypes

Clinical Cancer Research

Volumn 9, Issue 8, 2003, Pages 2879-2881

  Issa, Jean Pierre J ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b EPIGENOMICS AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; CANCER SURVIVAL; DISEASE COURSE; DNA METHYLATION; EDITORIAL; GENE SILENCING; HUMAN; MOLECULAR CLOCK; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS;

BIOLOGICAL CLOCKS; DISEASE PROGRESSION; DNA METHYLATION; FEMALE; HUMANS; MALE; NEOPLASMS; PHENOTYPE; PROGNOSIS;

EID: 0042025123     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (33)

1. Jones, P. A., and Takai, D. The role of DNA methylation in mammalian epigenetics. Science (Wash. DC), 293: 1068-1070, 2001.
2. Jones, P. A., and Laird, P. W. Cancer epigenetics comes of age. Nat. Genet., 21: 163-167, 1999.
3. Brock, M. V., Gou M. G., Akiyama Y., Muller A., Wu T. T., Montgomery E., Deasel, M., Germonpre, P., Rubinson, L., Heitmiller, R. F., Yang, S. C., Forastiere, A. A., Baylin, S. B., and Herman, J. G. Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma. Clin. Cancer Res., 9: 2912-2919, 2003.
4. Li, Q., Kopecky, K. J., Mohan, A., Willman, C. L., Appelbaum, F. R., Weick, J. K., and Issa, J. P. Estrogen receptor methylation is associated with improved survival in adult acute myeloid leukemia. Clin. Cancer Res., 5: 1077-1084, 1999.
5. Esteller, M., Gaidano, G., Goodman, S. N., Zagonel, V., Capello, D., Botto, B., Rossi, D., Gloghini, A., Vitolo, U., Carbone, A., Baylin, S. B., and Herman, J. G. Hypermethylation of the DNA repair gene o(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma. J. Natl. Cancer Inst., 94: 26-32, 2002.
6. Tang, X., Khuri, F. R., Lee, J. J., Kemp, B. L., Liu, D., Hong, W. K., and Mao, L. Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer. J. Natl. Cancer Inst., 92: 1511-1516, 2000.
7. Hanahan, D., and Weinberg, R. A. The hallmarks of cancer. Cell, 100: 57-70, 2000.
8. Maruyama, R., Toyooka, S., Toyooka, K. O., Harada, K., Virmani, A. K., Zochbauer-Muller, S., Farinas, A. J., Vakar-Lopez, F., Minna, J. D., Sagalowsky, A., Czerniak, B., and Gazdar, A. F. Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. Cancer Res., 61: 8659-8663, 2001.
9. Ogi, K., Toyota, M., Ohe-Toyota, M., Tanaka, N., Noguchi, M., Sonoda, T., Kohama, G., and Tokino, T. Aberrant methylation of multiple genes and clinicopathological feature in oral squamous cell carcinoma. Clin. Cancer Res., 8: 3164-3171, 2002.
10. Wei, S. H., Chen, C. M., Strathdee, G., Harnsomburana, J., Shyu, C. R., Rahmatpanah, F., Shi, H., Ng, S. W., Yan, P. S., Nephew, K. P., Brown, R., and Huang, T. H. Methylatlon microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers. Clin. Cancer Res., 8: 2246-2252, 2002.
11. Shen, L., Toyota, M., Kondo, Y., Obata, T., Daniel, S., Pierce, S., Imai, K., Kantarjian, H. M., Issa, J. P., and Garcia-Manero, G. Aberrant DNA methylation of p57KIP2 identifies a cell cycle regulatory pathway with prognostic impact in adult acute lymphocytic leukemia. Blood, 2003.
12. Kim, D. H., Nelson, H. H., Wiencke, J. K., Zheng, S., Christiani, D. C., Wain, J. C., Mark, E. J., and Kelsey, K. T. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res., 61: 3419-3424, 2001.
13. Hayashi, H., Yazawa, T., Okudela, K., Nagai, J., Ito, T., Kanisawa, M., and Kitamura, H. Inactivation of O6-methylguanine-DNA methyltransferase in human lung adenocarcinoma relates to high-grade histology and worse prognosis among smokers. Jpn. J. Cancer Res., 93: 184-189, 2002.
14. Chang, Y. S., Wang, L., Liu, D., Mao, L., Hong, W. K., Khuri, F. R., and Lee, H. Y. Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer. Clin. Cancer Res., 8: 3669-3675, 2002.
15. Velicescu, M., Weisenberger, D. J., Gonzales, F. A., Tsai, Y. C., Nguyen, C. T., and Jones, P. A. Cell division is required for de novo methylation of CpG islands in bladder cancer cells. Cancer Res., 62: 2378-2384, 2002.
16. Issa, J. P., Ottaviano, Y. L., Celano, P., Hamilton, S. R., Davidson, N. E., and Baylin, S. B. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat. Genet., 7: 536-540, 1994.
17. Issa, J. P. The epigenetics of colorectal cancer. Ann. N. Y. Acad. Sci., 910: 140-153, 2000.
18. Issa, J. P., Ahuja, N., Toyota, M., Bronner, M. P., and Brentnall, T. A. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res., 61: 3573-3577, 2001.
19. Eads, C. A., Lord, R. V., Wickramasinghe, K., Long, T. I., Kurumboor, S. K., Bernstein, L., Peters, J. H., DeMeester, S. R., DeMeester, T. R., Skinner, K. A., and Laird, P. W. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res., 61: 3410-3418, 2001.
20. Zion, M., Ben-Yehuda, D., Avraham, A., Cohen, O., Wetzler, M., Melloul, D., and Ben-Neriah, Y. Progressive de novo dna methylation at the bcr-abl locus in the course of chronic myelogenous leukemia. Proc. Natl. Acad. Sci. USA 91: 10722-10726, 1994.
21. Issa, J. P. J., Kantarjian, H. M., Mohan, A., O'Brien, S., Cortes, J., Pierce, S., and Talpaz, M. Methylation of the ABL1 promoter in chronic myelogenous leukemia: lack of prognostic significance. Blood, 93: 2075-2080, 1999.
22. Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., and Issa, J. P. J. CpG island methylator phenotype in colorectal cancer. Proc. Natl. Acad. Sci. USA, 96: 8681-8686, 1999.
23. Toyota, M., Ohe-Toyota, M., Ahuja, N., and Issa, J. P. Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. Proc. Natl. Acad. Sci. USA, 97: 710-715, 2000.
24. van Rijnsoever, M., Grieu, F., Elsaleh, H., Joseph, D., and Iacopetta, B. Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands. Gut, 51: 797-802, 2002.
25. Whitehall, V. L., Wynter, C. V., Walsh, M. D., Simms, L. A., Purdie, D., Pandeya, N., Young, J., Meltzer, S. J., Leggett, B. A., and Jass, J. R. Morphological and molecular heterogeneity within nonmicrosatellite instability-high colorectal cancer. Cancer Res., 62: 6011-6014, 2002.
26. Strathdee, G., Appleton, K., Illand, M., Millan, D. W., Sargent, J., Paul, J., and Brown, R. Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes. Am. J. Pathol., 158: 1121-1127, 2001.
27. Shen, L., Ahuja, N., Shen, Y., Habib, N. A., Toyota, M., Rashid, A., and Issa, J. P. DNA methylation and environmental exposures in human hepatocellular carcinoma. J. Natl. Cancer Inst., 94: 755-761, 2002.
28. Toyota, M., Kopecky, K. J., Toyota, M. O., Jair, K. W., Willman, C. L., and Issa, J. P. Methylation profiling in acute myeloid leukemia. Blood, 97: 2823-2829, 2001.
29. Widschwendter, M., and Jones, P. A. The potential prognostic, predictive, and therapeutic values of DNA methylation in cancer. Commentary re: J. Kwong et al., Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clin. Cancer Res., 8: 131-137, 2002,
30. H-Z. Zou et al., Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Clin. Cancer Res., 8: 188-191, 2002.
31. Clin. Cancer Res., 8: 17-21, 2002.
32. Santini, V., Kantarjian, H. M., and Issa, J. P. Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications. Ann. Intern. Med., 134: 573-586, 2001.
33. Daskalakis, M., Nguyen, T. T., Nguyen, C., Guldberg, P., Kohler, G., Wijermans, P., Jones, P. A., and Lubbert, M. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2Κ-deoxycytidine (decitabine) treatment. Blood, 100: 2957-2964, 2002.